Nifty

:

20855.10

Sensex

:

69296.14

168.30 (0.81%)
431.02 (0.63%)

Login

Nifty
Sensex

:
:

20855.10
69296.14

168.30 (0.81%)
431.02 (0.63%)

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

57/99

BSE: 524816 | NSE: NATCOPHARM

Watchlist

NSE BSE

780.20

05-Dec-2023

Open
High
Low
Previous Close

794.50
794.70
778.50
792.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

484920
3804.96
928.00
502.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

13,976.84
12.58
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,496.14
0.70%
2.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.87
5.27
9.67

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.66
2.78
8.59

PAT CAGR (%)

10 Years
5 Years
3 Years

21.42
2.11
17.50

P:E (Median)

8 Years
5 Years
3 Years

29.59
26.27
33.92

P:BV (Average)

8 Years
5 Years
3 Years

4.64
3.23
3.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.62
19.23
22.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 930.50 351.10 165.02% 1,048.30 805.70 30.11% 781.20 514.10 51.95% 413.00 529.50 -22.00%
Expenses 488.20 281.00 73.74% 544.60 426.30 27.75% 453.50 551.80 -17.81% 345.50 441.80 -21.80%
EBITDA 442.30 70.10 530.96% 503.70 379.40 32.76% 327.70 -37.70 - 67.50 87.70 -23.03%
EBIDTM 47.53% 19.97% 48.05% 47.09% 41.95% -7.33% 16.34% 16.56%
Other Income 24.70 16.20 52.47% 14.60 33.20 -56.02% 17.50 10.40 68.27% 18.60 31.60 -41.14%
Interest 3.00 1.70 76.47% 3.20 2.70 18.52% 1.20 4.20 -71.43% 3.00 4.10 -26.83%
Depreciation 40.00 38.30 4.44% 39.90 36.90 8.13% 37.60 35.60 5.62% 38.10 35.50 7.32%
PBT 424.00 46.30 815.77% 475.20 373.00 27.40% 306.40 -67.10 - 45.00 79.70 -43.54%
Tax 63.80 8.60 641.86% 69.90 65.00 7.54% 52.30 -5.80 - 7.70 8.10 -4.94%
PAT 360.20 37.70 855.44% 405.30 308.00 31.59% 254.10 -61.30 - 37.30 71.60 -47.91%
PATM 38.71% 10.74% 38.66% 38.23% 32.53% -11.92% 9.03% 13.52%
EPS 20.11 2.10 857.62% 22.63 17.20 31.57% 14.19 -3.42 - 2.08 4.00 -48.00%

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 1,031.40 432.10 138.69% 1,140.50 884.60 28.93% 897.90 596.80 50.45% 492.50 560.50 -12.13%
Expenses 573.40 336.80 70.25% 612.50 489.30 25.18% 558.80 615.40 -9.20% 386.60 458.70 -15.72%
EBITDA 458.00 95.30 380.59% 528.00 395.30 33.57% 339.10 -18.60 - 105.90 101.80 4.03%
EBIDTM 44.41% 22.06% 46.30% 44.69% 37.77% -3.12% 21.50% 18.16%
Other Income 29.40 20.50 43.41% 19.70 34.30 -42.57% 29.00 13.80 110.14% 20.80 30.20 -31.13%
Interest 4.20 3.80 10.53% 4.20 4.20 0.00% 2.70 6.70 -59.70% 3.80 5.00 -24.00%
Depreciation 43.60 41.70 4.56% 43.50 39.60 9.85% 41.00 38.10 7.61% 41.50 36.00 15.28%
PBT 439.60 70.30 525.32% 500.00 385.80 29.60% 324.40 -49.60 - 81.40 91.00 -10.55%
Tax 70.60 13.50 422.96% 79.70 65.40 21.87% 48.60 0.90 5,300.00% 19.10 10.60 80.19%
PAT 369.00 56.80 549.65% 420.30 320.40 31.18% 275.80 -50.50 - 62.30 80.40 -22.51%
PATM 35.78% 13.15% 36.85% 36.22% 30.72% -8.46% 12.65% 14.34%
EPS 20.61 3.11 562.70% 23.48 17.56 33.71% 15.11 -2.77 - 3.41 4.41 -22.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,173.00 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 715.55 622.34 Net Sales Growth 44.20% 32.99% 6.91% -7.64% -9.87% -5.02% 6.81% 91.70% 42.74% 14.98% Cost Of Goods Sold 680.80 485.60 502.10 472.30 369.80 317.60 388.50 572.80 256.30 170.70 150.73 Gross Profit 2,492.20 1,865.40 1,265.70 1,181.20 1,420.40 1,668.70 1,702.80 1,385.20 765.10 544.85 471.61 GP Margin 78.54% 79.34% 71.60% 71.44% 79.34% 84.01% 81.42% 70.75% 74.91% 76.14% 75.78% Total Expenditure 1,831.80 1,530.20 1,554.80 1,238.30 1,212.20 1,169.80 1,162.90 1,266.00 740.70 486.99 435.76 Power & Fuel Cost - 81.90 76.40 59.40 62.40 59.60 56.10 50.50 43.70 40.49 40.69 % Of Sales - 3.48% 4.32% 3.59% 3.49% 3.00% 2.68% 2.58% 4.28% 5.66% 6.54% Employee Cost - 425.70 410.10 380.00 356.10 340.20 312.20 232.10 171.90 116.19 94.22 % Of Sales - 18.11% 23.20% 22.98% 19.89% 17.13% 14.93% 11.85% 16.83% 16.24% 15.14% Manufacturing Exp. - 269.90 340.80 160.50 230.40 257.50 175.10 134.20 100.60 65.41 70.48 % Of Sales - 11.48% 19.28% 9.71% 12.87% 12.96% 8.37% 6.85% 9.85% 9.14% 11.32% General & Admin Exp. - 155.70 122.50 92.60 111.20 103.90 96.00 78.30 56.90 48.57 46.44 % Of Sales - 6.62% 6.93% 5.60% 6.21% 5.23% 4.59% 4.00% 5.57% 6.79% 7.46% Selling & Distn. Exp. - 59.50 27.00 29.20 22.60 33.50 98.00 128.80 88.40 34.29 24.47 % Of Sales - 2.53% 1.53% 1.77% 1.26% 1.69% 4.69% 6.58% 8.65% 4.79% 3.93% Miscellaneous Exp. - 51.90 75.90 44.30 59.70 57.50 37.00 69.30 22.90 11.33 24.47 % Of Sales - 2.21% 4.29% 2.68% 3.33% 2.89% 1.77% 3.54% 2.24% 1.58% 1.40% EBITDA 1,341.20 820.80 213.00 415.20 578.00 816.50 928.40 692.00 280.70 228.56 186.58 EBITDA Margin 42.27% 34.91% 12.05% 25.11% 32.29% 41.11% 44.39% 35.34% 27.48% 31.94% 29.98% Other Income 75.40 109.40 94.60 103.50 123.80 129.80 39.40 13.20 12.90 13.57 15.71 Interest 10.40 8.60 13.30 11.30 20.60 18.80 14.70 17.50 21.90 30.13 34.06 Depreciation 155.60 150.90 138.40 115.20 98.10 80.10 65.50 53.60 50.20 42.46 26.79 PBT 1,250.60 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 169.54 141.45 Tax 193.70 133.60 16.80 82.70 108.60 180.30 189.40 139.30 45.00 1.48 31.26 Tax Rate 15.49% 17.33% 10.78% 21.09% 18.62% 21.28% 21.34% 21.97% 20.32% 0.96% 22.10% PAT 1,056.90 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 110.19 PAT before Minority Interest 1,056.90 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 110.19 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 33.31% 27.10% 7.87% 18.72% 26.51% 33.59% 33.39% 25.27% 17.28% 21.37% 17.71% PAT Growth 196.88% 358.02% -55.06% -34.77% -28.87% -4.45% 41.11% 180.34% 15.41% 38.79% EPS 59.01 35.57 7.77 17.28 26.49 37.25 38.98 27.63 9.85 8.54 6.15

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,562.30 2,707.10 1,944.80 2,052.10 1,915.00 2,094.50 2,184.80 2,020.20 1,141.30 825.28 738.89 Net Sales Growth 43.99% 39.20% -5.23% 7.16% -8.57% -4.13% 8.15% 77.01% 38.29% 11.69% Cost Of Goods Sold 785.60 583.20 528.40 483.70 354.40 332.70 411.10 599.10 341.10 242.37 233.23 Gross Profit 2,776.70 2,123.90 1,416.40 1,568.40 1,560.60 1,761.80 1,773.70 1,421.10 800.20 582.90 505.67 GP Margin 77.95% 78.46% 72.83% 76.43% 81.49% 84.12% 81.18% 70.34% 70.11% 70.63% 68.44% Total Expenditure 2,131.30 1,795.40 1,681.30 1,448.30 1,332.40 1,299.70 1,256.40 1,336.80 868.70 611.90 559.56 Power & Fuel Cost - 81.90 76.40 61.10 62.40 59.60 56.20 50.50 43.70 43.24 44.77 % Of Sales - 3.03% 3.93% 2.98% 3.26% 2.85% 2.57% 2.50% 3.83% 5.24% 6.06% Employee Cost - 486.70 444.80 414.90 375.00 355.90 325.60 243.20 189.60 136.92 112.77 % Of Sales - 17.98% 22.87% 20.22% 19.58% 16.99% 14.90% 12.04% 16.61% 16.59% 15.26% Manufacturing Exp. - 279.60 353.60 165.70 243.30 276.40 182.60 141.20 105.20 73.04 76.57 % Of Sales - 10.33% 18.18% 8.07% 12.70% 13.20% 8.36% 6.99% 9.22% 8.85% 10.36% General & Admin Exp. - 208.80 152.80 242.90 132.60 126.40 105.50 88.10 73.40 63.66 56.21 % Of Sales - 7.71% 7.86% 11.84% 6.92% 6.03% 4.83% 4.36% 6.43% 7.71% 7.61% Selling & Distn. Exp. - 96.10 43.70 34.40 98.10 90.00 136.90 143.20 91.60 37.36 26.16 % Of Sales - 3.55% 2.25% 1.68% 5.12% 4.30% 6.27% 7.09% 8.03% 4.53% 3.54% Miscellaneous Exp. - 59.10 81.60 45.60 66.60 58.70 38.50 71.50 24.10 15.31 26.16 % Of Sales - 2.18% 4.20% 2.22% 3.48% 2.80% 1.76% 3.54% 2.11% 1.86% 1.33% EBITDA 1,431.00 911.70 263.50 603.80 582.60 794.80 928.40 683.40 272.60 213.38 179.33 EBITDA Margin 40.17% 33.68% 13.55% 29.42% 30.42% 37.95% 42.49% 33.83% 23.89% 25.86% 24.27% Other Income 98.90 128.50 99.00 106.00 107.40 130.20 40.40 13.90 9.90 14.91 16.71 Interest 14.90 14.50 17.70 13.30 21.50 19.30 15.40 18.50 22.90 31.68 36.62 Depreciation 169.60 163.80 142.60 116.90 99.80 81.00 66.20 54.40 51.00 47.27 30.44 PBT 1,345.40 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 149.34 128.98 Tax 218.00 146.60 32.20 137.20 110.60 182.30 192.00 139.50 52.80 3.95 30.87 Tax Rate 16.20% 17.01% 15.92% 23.67% 19.45% 22.11% 21.64% 22.34% 25.31% 2.94% 23.93% PAT 1,127.40 715.30 170.00 440.90 460.80 644.40 696.20 486.00 157.10 134.62 102.74 PAT before Minority Interest 1,127.40 715.30 170.00 442.40 458.10 642.40 695.20 484.90 155.80 130.27 98.11 Minority Interest 0.00 0.00 0.00 -1.50 2.70 2.00 1.00 1.10 1.30 4.35 4.63 PAT Margin 31.65% 26.42% 8.74% 21.49% 24.06% 30.77% 31.87% 24.06% 13.77% 16.31% 13.90% PAT Growth 176.93% 320.76% -61.44% -4.32% -28.49% -7.44% 43.25% 209.36% 16.70% 31.03% EPS 62.95 39.94 9.49 24.62 25.73 35.98 38.87 27.14 8.77 7.52 5.74

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 4,702.00 4,191.90 4,091.10 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 878.99 732.90 Share Capital 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 33.07 Total Reserves 4,665.50 4,152.00 4,037.00 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 845.76 699.83 Non-Current Liabilities 116.90 134.90 142.90 117.50 83.10 47.00 37.70 27.90 117.53 148.62 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 96.28 94.97 Unsecured Loans 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.19 10.63 Current Liabilities 569.00 651.20 518.50 659.70 709.80 563.80 609.70 478.50 398.31 294.71 Trade Payables 182.40 141.20 139.50 234.20 201.80 245.40 251.40 270.10 115.34 99.18 Other Current Liabilities 201.40 104.00 111.10 93.40 108.50 131.70 122.80 110.90 113.32 96.48 Short Term Borrowings 159.90 389.00 255.10 313.10 384.50 173.00 220.60 96.00 168.54 98.63 Short Term Provisions 25.30 17.00 12.80 19.00 15.00 13.70 14.90 1.50 1.11 0.41 Total Liabilities 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 1,176.23 Net Block 2,233.80 2,174.20 2,005.90 1,574.50 1,214.90 1,015.30 829.00 705.60 572.74 528.98 Gross Block 3,157.10 2,977.80 2,678.30 2,133.70 1,678.20 1,399.60 1,151.00 975.90 783.12 690.82 Accumulated Depreciation 923.30 803.60 672.40 559.20 463.30 384.30 322.00 270.30 210.39 161.84 Non Current Assets 2,893.20 2,810.30 2,584.00 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 950.65 838.88 Capital Work in Progress 62.80 128.70 223.40 517.80 637.50 480.00 336.20 211.90 100.77 92.94 Non Current Investment 517.60 430.40 294.90 186.10 117.60 101.30 85.90 71.70 131.15 88.58 Long Term Loans & Adv. 78.80 72.40 55.60 124.30 110.40 83.10 60.40 62.00 142.47 125.16 Other Non Current Assets 0.20 4.60 4.20 4.10 8.30 2.30 0.50 0.60 3.52 3.22 Current Assets 2,494.70 2,167.70 2,168.50 2,239.90 2,267.40 2,054.20 1,035.10 790.90 444.18 337.35 Current Investments 139.90 119.60 42.10 5.00 126.80 48.30 8.90 22.10 0.12 0.32 Inventories 616.00 697.70 769.20 524.40 508.40 425.80 336.90 351.90 198.35 161.97 Sundry Debtors 793.10 575.60 399.80 536.70 491.60 606.00 468.90 255.80 188.96 115.85 Cash & Bank 412.00 100.90 262.80 54.10 262.70 172.10 25.10 40.20 7.19 7.70 Other Current Assets 533.70 78.10 95.20 93.80 877.90 802.00 195.30 120.90 49.57 51.53 Short Term Loans & Adv. 476.10 595.80 599.40 1,025.90 769.50 748.80 169.60 95.50 43.99 47.35 Net Current Assets 1,925.70 1,516.50 1,650.00 1,580.20 1,557.60 1,490.40 425.40 312.40 45.87 42.64 Total Assets 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 1,176.23

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 4,873.80 4,263.60 4,121.60 3,773.50 3,489.00 3,072.20 1,649.30 1,295.70 846.05 725.88 Share Capital 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 33.07 Total Reserves 4,837.30 4,223.70 4,067.60 3,713.60 3,421.70 3,011.40 1,599.00 1,251.20 812.82 692.80 Non-Current Liabilities 100.50 135.10 142.90 117.80 83.40 47.10 37.70 28.00 119.23 150.67 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 94.03 92.20 Unsecured Loans 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 2.99 3.28 Long Term Provisions 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.50 11.09 Current Liabilities 683.10 710.40 525.60 685.30 728.70 592.00 626.50 493.10 413.74 312.28 Trade Payables 263.80 161.80 146.20 255.40 217.00 269.10 262.70 275.60 125.30 109.79 Other Current Liabilities 227.30 126.70 99.50 95.90 109.80 133.40 127.10 114.20 118.56 102.18 Short Term Borrowings 165.00 404.00 265.80 315.00 386.30 173.20 221.60 98.40 168.54 98.63 Short Term Provisions 27.00 17.90 14.10 19.00 15.60 16.30 15.10 4.90 1.33 1.69 Total Liabilities 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 1,195.71 Net Block 2,426.90 2,311.80 2,023.20 1,584.40 1,227.20 1,018.60 833.00 710.10 709.97 644.74 Gross Block 3,375.10 3,126.90 2,702.10 2,148.70 1,694.50 1,407.60 1,158.70 983.30 939.98 819.89 Accumulated Depreciation 948.20 815.10 678.90 564.30 467.30 389.00 325.70 273.20 225.82 171.11 Non Current Assets 2,657.10 2,622.40 2,447.10 2,262.20 1,955.90 1,584.40 1,230.30 984.70 901.08 827.57 Capital Work in Progress 64.30 129.50 223.40 518.00 637.60 480.00 336.30 211.80 128.96 123.78 Non Current Investment 87.30 104.40 151.90 83.60 19.90 8.10 0.10 0.10 1.57 1.57 Long Term Loans & Adv. 78.30 72.00 44.30 72.00 62.80 75.40 60.40 62.10 57.03 54.25 Other Non Current Assets 0.30 4.70 4.30 4.20 8.40 2.30 0.50 0.60 3.54 3.24 Current Assets 3,000.30 2,486.70 2,344.80 2,325.60 2,347.20 2,130.70 1,087.30 837.00 482.97 368.14 Current Investments 305.00 203.70 151.80 28.70 148.70 68.40 32.10 22.10 0.12 0.32 Inventories 742.90 762.00 798.20 558.00 529.00 438.40 348.90 357.30 220.00 181.12 Sundry Debtors 856.10 620.60 412.90 551.30 506.20 637.50 475.20 261.60 192.43 118.80 Cash & Bank 546.30 206.10 283.50 66.00 279.50 183.70 35.80 45.20 13.36 11.05 Other Current Assets 550.00 88.10 94.70 91.60 883.80 802.70 195.30 150.80 57.06 56.85 Short Term Loans & Adv. 485.60 606.20 603.70 1,030.00 776.40 749.50 169.50 125.40 40.97 52.46 Net Current Assets 2,317.20 1,776.30 1,819.20 1,640.30 1,618.50 1,538.70 460.80 343.90 69.23 55.85 Total Assets 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 1,195.71

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 784.40 57.70 183.50 422.50 698.80 476.40 329.80 189.90 124.55 171.79 PBT 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 154.41 141.45 Adjustment 85.40 118.50 58.40 45.20 12.10 74.40 99.80 81.70 62.73 56.69 Changes in Working Capital 76.70 -184.20 -190.20 -100.70 14.20 -281.20 -281.70 -68.50 -72.49 6.11 Cash after chg. in Working capital 932.80 90.20 260.40 527.60 873.70 680.80 452.20 234.70 144.64 204.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -148.40 -32.50 -76.90 -105.10 -174.90 -204.40 -122.40 -44.80 -20.09 -32.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -436.60 -92.50 -3.20 -165.00 -645.20 -1,131.10 -290.60 -249.30 -147.95 -130.64 Net Fixed Assets -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 -99.70 Net Investments -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 -11.33 Others -215.70 325.30 392.90 117.50 -114.30 -683.90 9.80 17.14 -5.45 -19.61 Cash from Financing Activity -346.80 35.60 -183.10 -261.10 -52.20 652.00 -45.60 151.40 22.80 -40.96 Net Cash Inflow / Outflow 1.00 0.80 -2.80 -3.60 1.40 -2.70 -6.40 92.00 -0.59 0.19 Opening Cash & Equivalents 5.90 5.10 7.90 11.50 10.10 12.80 19.20 -170.00 6.86 6.67 Closing Cash & Equivalent 6.90 5.90 5.10 7.90 11.50 10.10 12.80 -76.80 6.27 6.86

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 849.10 46.50 298.80 417.30 668.80 463.60 345.80 112.20 92.67 144.03 PBT 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 134.22 128.98 Adjustment 102.00 123.90 62.10 54.00 14.30 75.60 100.20 90.50 68.14 65.72 Changes in Working Capital 62.70 -231.40 -212.90 -97.60 8.60 -294.60 -253.00 -140.70 -85.96 -16.11 Cash after chg. in Working capital 1,026.60 94.70 428.80 525.10 847.60 668.20 471.60 158.40 116.41 178.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -177.50 -48.20 -130.00 -107.80 -178.80 -204.60 -125.80 -46.20 -23.74 -34.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -477.10 -5.30 -103.30 -167.00 -612.20 -1,115.50 -299.40 -175.50 -114.75 -108.92 Net Fixed Assets -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 -99.70 Net Investments -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 -11.33 Others -256.20 412.50 292.80 115.50 -81.30 -668.30 1.00 90.94 27.75 2.11 Cash from Financing Activity -363.00 34.80 -185.70 -250.80 -50.90 650.90 -47.70 154.00 29.07 -35.27 Net Cash Inflow / Outflow 9.00 76.00 9.80 -0.50 5.70 -1.00 -1.30 90.70 6.99 -0.15 Opening Cash & Equivalents 111.10 25.80 19.80 28.30 21.70 23.50 24.20 -164.10 10.22 9.95 Closing Cash & Equivalent 131.90 111.10 25.80 19.80 28.30 21.70 23.50 -74.20 12.44 10.22

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 257.64 229.51 223.21 211.31 193.55 168.09 96.52 76.24 52.90 221.60 ROA 12.29% 2.86% 6.59% 10.54% 16.49% 22.95% 23.62% 10.90% 11.90% 9.87% ROE 14.33% 3.37% 7.82% 12.86% 20.11% 29.18% 32.87% 16.00% 18.97% 17.35% ROCE 16.51% 3.79% 9.46% 14.85% 23.91% 34.58% 38.71% 18.48% 17.10% 19.04% Fixed Asset Turnover 0.78 0.65 0.70 0.99 1.41 1.65 1.88 1.20 0.99 0.97 Receivable days 104.18 96.61 101.41 99.38 92.04 93.04 66.04 76.63 76.52 70.40 Inventory Days 100.00 145.29 140.07 99.81 78.34 66.02 62.77 94.81 90.45 84.34 Payable days 121.62 102.03 144.40 66.65 73.69 81.82 79.78 95.04 82.23 86.11 Cash Conversion Cycle 82.56 139.87 97.08 132.54 96.69 77.23 49.02 76.39 84.74 68.63 Total Debt/Equity 0.03 0.09 0.06 0.08 0.11 0.06 0.13 0.08 0.35 0.32 Interest Cover 90.62 12.72 35.71 29.31 46.07 61.38 37.23 11.11 6.12 5.15

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 267.06 233.44 224.88 206.04 189.49 165.22 93.63 73.91 50.91 219.48 ROA 13.29% 3.43% 9.43% 10.30% 16.02% 23.05% 23.43% 9.72% 10.10% 8.62% ROE 15.66% 4.06% 11.27% 12.71% 19.75% 29.70% 33.21% 14.62% 16.57% 15.58% ROCE 18.06% 4.86% 13.99% 14.82% 23.71% 35.28% 39.21% 18.04% 15.62% 18.02% Fixed Asset Turnover 0.89 0.76 0.86 1.07 1.47 1.72 1.93 1.23 0.95 0.96 Receivable days 93.53 85.10 84.44 93.77 91.36 92.22 65.12 70.27 67.76 60.90 Inventory Days 95.32 128.47 118.77 96.38 77.28 65.25 62.41 89.35 87.33 80.17 Payable days 133.18 106.38 151.52 65.96 72.53 81.42 78.30 85.42 73.36 74.09 Cash Conversion Cycle 55.67 107.20 51.68 124.19 96.11 76.05 49.23 74.21 81.73 66.99 Total Debt/Equity 0.03 0.09 0.06 0.08 0.11 0.06 0.14 0.09 0.37 0.33 Interest Cover 60.44 12.42 44.58 27.45 43.73 58.61 34.75 10.11 5.24 4.52

Top Investors:

life insurance corporation of india

mirae asset healthcare fund

icici prudential multicap fund

nomura singapore limited odi

quant mutual fund - quant business cycle fund

akash bhanshali

tata mutual fund - tata small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Natco Pharma - Quarterly Results
14th Nov 2023, 14:14 PM

Read More
Natco Pharma makes strategic investment in ISCA Inc
31st Aug 2023, 10:23 AM

Cost of acquisition is $2 million
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback